These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6643342)

  • 41. [Production of enterotoxins by Bacteroids fragilis strains--effect of clindamycin].
    Rokosz A; Rouyan GS; Meisel-Mikołajczyk F
    Med Dosw Mikrobiol; 1997; 49(3-4):153-9. PubMed ID: 9554147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Presence of two unique genes encoding macrolide-lincosamide-streptogramin resistance in members of the Bacteroides fragilis group as determined by DNA-DNA homology.
    Callihan DR; Young FE; Clark VL
    J Antimicrob Chemother; 1984 Oct; 14(4):329-38. PubMed ID: 6438043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined activity of clindamycin and gentamicin on Bacteroides fragilis and other bacteria.
    Okubadejo OA; Allen J
    J Antimicrob Chemother; 1975 Dec; 1(4):403-9. PubMed ID: 812858
    [No Abstract]   [Full Text] [Related]  

  • 44. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Use of the LAL test for quantitative determination of Bacteroids fragilis endotoxin].
    Rokosz A; Marciniak-Rusek A; Aleksandrowicz J; Meisel-Mikołajczyk F
    Med Dosw Mikrobiol; 1997; 49(3-4):161-8. PubMed ID: 9554148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In-vivo effects of clindamycin on polymorphonuclear leucocyte phagocytosis and killing of gram-negative organisms.
    Bassaris HP; Lianou PE; Skoutelis AT; Papavassiliou JT
    J Antimicrob Chemother; 1987 Apr; 19(4):467-73. PubMed ID: 3583968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increasing incidence of clinical isolates of Bacteroides fragilis resistant to clindamycin.
    Soriano F; Ponte C; Wilhelmi I
    J Antimicrob Chemother; 1984 Apr; 13(4):395. PubMed ID: 6725185
    [No Abstract]   [Full Text] [Related]  

  • 49. [Infections caused by Bacteroides fragilis resistant to clindamycin: 2 further cases].
    Andrieu J; Kwantes M; Lapeyrere X; Gardon JD
    Nouv Presse Med; 1978 Feb; 7(7):571-2. PubMed ID: 643586
    [No Abstract]   [Full Text] [Related]  

  • 50. Susceptibility studies in the Bacteroides fragilis group resistant to clindamycin.
    Liñares J; Pérez JL; Martín R
    J Antimicrob Chemother; 1983 Sep; 12(3):293. PubMed ID: 6630117
    [No Abstract]   [Full Text] [Related]  

  • 51. [Bacteroides fragilis. Its isolation and antibiotic sensitivity].
    Cancet B; Nadaud M
    Ann Biol Clin (Paris); 1976; 34(2):133-7. PubMed ID: 970703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of humoral factors in host resistance to the Bacteroides fragilis group.
    Bjornson AB
    Rev Infect Dis; 1990; 12 Suppl 2():S161-8. PubMed ID: 2406868
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics.
    Glupczynski Y; Gordts B; van der Linden MP; Labbé M; Yourassowsky E; Butzler JP
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transfer of tetracycline or clindamycin resistance among strains of Bacteroides fragilis in experimental abscesses.
    Butler E; Joiner KA; Malamy M; Bartlett JC; Tally FP
    J Infect Dis; 1984 Jul; 150(1):20-4. PubMed ID: 6747344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative study of clindamycin, imipenem, oxacillin and vancomycin in the infected granuloma pouch model.
    Brauner E; Gorbach S; Davey P
    J Antimicrob Chemother; 1989 Jun; 23(6):891-8. PubMed ID: 2759932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of clindamycin on the intracellular bactericidal capacity of human peritoneal macrophages.
    de Fijter CW; Verbrugh HA; Heezius HC; van der Meulen J; Oe PL; Donker AJ; Verhoef J
    J Antimicrob Chemother; 1990 Oct; 26(4):525-32. PubMed ID: 2254222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacteroides fragilis resistant to metronidazole, clindamycin and cefoxitin.
    Brogan O; Garnett PA; Brown R
    J Antimicrob Chemother; 1989 Apr; 23(4):660-2. PubMed ID: 2745269
    [No Abstract]   [Full Text] [Related]  

  • 58. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
    Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
    Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variations in susceptibility to latamoxef(moxalactam) and cefoxitin within the Bacteroides fragilis group.
    Eley A; Greenwood D
    J Antimicrob Chemother; 1984 Mar; 13(3):245-55. PubMed ID: 6725175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of subminimal inhibitory concentrations of clindamycin and gram-negative aerobic organisms: effects on adhesion and polymorphonuclear leukocyte function.
    Lianou PE; Bassaris HP; Votta EG; Papavassiliou JT
    J Antimicrob Chemother; 1985 Apr; 15(4):481-7. PubMed ID: 4008380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.